Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-020381)

Filing Details

Accession Number:: 0001209191-14-020381
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2014-03-13 17:51:18
Reporting Period:: 2013-12-06

Filing Date:: 2014-03-13
Accepted Time:: 2014-03-13 17:51:18
Original Submission Date:: 2013-12-06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1326732	Xencor Inc	XNCR	Pharmaceutical Preparations (2834)	201622502

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1218981	Iii S John Stafford	350 N. Orleans, 2N Chicago IL 60654		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-12-06	7,260,773	$0.00	7,283,631	No	4	C	Direct
Common Stock	Acquisiton	2013-12-06	275,000	$5.50	7,558,631	No	4	P	Direct
Common Stock	Acquisiton	2013-12-06	282,572	$0.00	282,572	No	4	C	Indirect	By Drogheda, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct
No	4	C	Indirect	By Drogheda, LLC

Footnotes

Every 3.1 shares of the Series A-1 Preferred Stock is convertible into 1 share of the Issuer's Common Stock at any time, at the holder's election, and has no expiration date.
The shares were purchased at the Issuer's initial public offering.
This Form 4 is being amended to correct the amount of securities beneficially owned following the reported transactions with respect to the direct and indirect holdings.